Friday, October 14th

7:00 – 8:00am

Registration | Breakfast | Exhibits

8:00 – 8:45am

Session #1 – Research at Work

8:45 – 9:30am

Keynote – RGC Transplantation and Optic Nerve Regeneration

9:30 – 10:00am

Break | Exhibits

10:00 – 10:45am

Session #2 – Experiences in International and Public Health Glaucoma

  • Vision Rehabilitation
  • Overseas Work
  • Blindes Prevention in Quebec
  • Indigenous / Refugee Care

10:45 – 11:30am

Session #3 – Presbyopic Correction in the Glaucoma Patient (Cases)

  • Case #1 – Young Patient for Angle Closure
  • Case #2 – Monocular Surgery in High Myope
  • Case #3 – Different Stages of Glaucoma

11:30 – 12:30pm

Keynote – Glaucoma Beyond the Office

  • Remote Tonometry
  • Practical Telemedicine

12:30 – 1:00pm

Lunch | Exhibits

6:30 – 8:30pm

CGS Welcome Reception


Saturday, October 15th 

8:00 – 9:00am

Breakfast | Exhibits

9:00 – 9:45am

Session #4 – Imaging

  • Octopus vs. Medmont vs. AI

9:45 – 10:30am

Keynote – Neuroprotection and the Future

10:30 – 11:00am

Break | Exhibits

11:00 – 11:45am

Session #5 – Glaucoma Surgery

  • ECP/Micropulse
  • GATT
  • TM Bypass
  • Xen45 vs Xen63
  • Preserflo
  • Clearpath
  • MMC in Valved Surgery

11:45 – 12:30pm

Surgical Panel

12:30 – 12:45pm

Closing Remarks

12:45pm – 2:00pm

Served Lunch & CGS Business Meeting

6:00pm – 10:00pm

CGS Dinner (Location TBD)

Guest Speaker

Thomas V. Johnson III, MD, PhD

Dr. Johnson is a clinician-scientist and the Allan and Shelly Holt Rising Professor of Ophthalmology at the Wilmer Eye Institute at Johns Hopkins University. He completed hisPhD in neuroscience at the University of Cambridge (UK) where his doctoral research evaluated mesenchymal stem cell transplantation as a potential neuroprotective treatment for glaucoma. He has been at Johns Hopkins since 2010 where he completed medical school, ophthalmology residency, glaucoma fellowship, and served as the Wilmer Eye Institute’s Assistant Chief of Service (ACS). Dr. Johnson is a glaucoma specialist and treats patients in the clinic and operating room for 1-2 days per week. The remainder of his time is spent in his translational neuroscience laboratory where is he investigating retinal ganglion cell replacement therapies for vision restoration in glaucoma and other optic neuropathies. He is especially interested in the functional engraftment of transplanted neurons into mature and diseased retinal circuitries. As a strong advocate of open science and collaborative research, Dr. Johnson serves as the Chair of the Organizing Committee for the international RGC Repopulation, Stem Cell Transplantation, and Optic Nerve Regeneration (RReSTORe) Consortium. He also has a clinical interest in understanding the relationship between intraocular pressure and glaucoma progression, especially through remote tonometry. View full CV.